HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 07, July 2018 – Water management- Technologies for biotech and pharmaceutical industries       » Why sunshine improves mood and makes us smarter       » SGD110 million lab to create healthier foods and sustainable biochemicals       » Entries open for the USD170,000 Ryman Prize       » Could the eye be the window to brain degeneration?       » High vitamin D levels linked to lower cholesterol in children      
INSIDE INDUSTRY
Singapore’s pharmaceutical market value to reach $1.15 billion by 2021
Singapore’s healthcare market is driven by universal access to health insurance schemes and world-class biomedical sciences research facilities. However, the market is still small due to the small population, says GlobalData.

Singapore’s pharmaceutical market is expected to expand from $903 million in 2016 to $1.15 billion by 2021, according to GlobalData, a leading data and analytics company.

The company’s latest report: ‘CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Singapore’ reveals that Singapore’s healthcare market is driven by universal access to health insurance schemes and world-class biomedical sciences research facilities. However, the market is small in comparison to those of other developed countries, primarily due to the small population.

In 2010, Singapore was ranked fourth globally for its healthcare infrastructure, according to the Institute for Management Development. Efficient healthcare infrastructure and increasing public healthcare expenditure are expected to drive the market.

Sama Khan, Healthcare Analyst at GlobalData, comments: “Singapore develops pharmaceuticals and medical devices at the medical technology hubs MedTech, Biopolis and Tuas Biomedical Park. The country has emerged as a regional hub for the manufacture and R&D activities of multinational pharmaceutical companies, and offers excellent opportunities for biomedical science companies via a pro-business environment, low unit labor costs, low corporate tax and strong government support.”

The medical device market is expected to grow as Singapore strengthens its position as the region’s healthcare hub. In 2015, the medical device market contributed $1.69 billion to Singapore’s output.

Khan continues: “While medical devices are imported primarily from the US, Japan and Germany, products such as syringes, catheters and research instruments are manufactured domestically. There are over 30 medical technology companies in Singapore that have set up commercial-scale plants to produce medical devices for the regional and global markets.”

Singapore offers a solid economy for investors due to the stable government and its initiatives. In 2016, Business Environment Risk Intelligence (BERI) ranked Singapore first among 50 countries as an investment destination. The country continues to boost its knowledge-based, free market economy, which is primarily dependent upon exports. It provides a corruption-free and open market environment.

Khan concludes: “The government offers universal healthcare coverage through a mixed financing system. Per-capita government expenditure on health increased from $1,656 in 2009 to $2,752 in 2014 according to the World Bank, and is expected to increase further over time due to the anticipated growth of the elderly population.”

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management- Technologies for biotech and pharmaceutical industries
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy